Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an international clinical trial network at the forefront of diabetes research, today announced a new collaboration agreement to evaluate Nektar's ...
The Kenya Times on MSN8hOpinion
Understanding Diabetes: Can It be Reversed? Who Can Get It? Is there a Special Diet for Those Who Have it?Understanding how to effectively live with diabetes and manage it to maintain a normal life is paramount for anyone affected ...
TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics ...
Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional ...
SurvivorNet on MSN4d
Blockbuster Weightless Drugs & Cancer Risk: Ozempic Changes Pancreas Cells, Experts Weigh In On Whether That’s WorrisomeGlucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, ...
Bile reflux gastritis (BRG) is a gastro-intestinal condition especially characterized by the reflux of bile into the stomach, further leading to mucosal inflammation along with various other clinical ...
Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...
Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...
The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback